Baylis Medical Agrees to Sell to Boston Scientific for $1.75 Billion
October 21, 2021
Cooley advised Baylis Medical on its agreement to sell its cardiology business to Boston Scientific for an upfront payment of $1.75 billion. Michael McGrail, Michal Berkner, William Corcoran, Jacqueline Grise and Joshua Friedman led the Cooley team advising Baylis Medical.
Otsuka Enters Worldwide Collaboration Agreement With Sunovion and Sumitomo Dainippon Pharma
October 13, 2021
Cooley advised Otsuka Pharmaceutical, a global healthcare company, on its worldwide collaboration and license agreement with biopharmaceutical company Sunovion Pharmaceuticals and parent company Sumitomo Dainippon Pharma for the joint development and commercialization of four novel candidate compounds. Lawyers Alison Freeman-Gleason and Brian Stalter led the Cooley team advising Otsuka.
Unchained Labs Agrees to Sell to The Carlyle Group
April 27, 2021
Cooley advised Unchained Labs on its agreement to sell to The Carlyle Group, a publicly traded global investment firm, for $435 million. Partners Mark Weeks, Anne Lieberman and Al Browne led the Cooley team advising Unchained Labs, a life sciences tools company focused on solving problems for biologics and gene therapy researchers.